Clinical Value of Radiographic Staging in Patients Diagnosed With AJCC Stage III Melanoma

Background Patients with American Joint Committee on Cancer (AJCC) stage III melanoma represent patients with high risk of systemic relapse. This study evaluates the clinical utility of standardized radiographic staging.